5-Chloro-1,3,4-thiadiazole-2-carbonitrile

Catalog No.: 
ACZMUD460
CAS No.: 
195737-25-8
Molecular Formula: 
C3ClN3S
Molecular Weight: 
145.57
5-Chloro-1,3,4-thiadiazole-2-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$332.00InquiryInquiry
100mg95%$488.00InquiryInquiry
250mg95%$692.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-1,3,4-thiadiazole-2-carbonitrile
IUPAC Name5-chloro-1,3,4-thiadiazole-2-carbonitrile
Molecular FormulaC3ClN3S
Molecular Weight145.57
SMILESN#CC1=NN=C(Cl)S1
InChI KeyCNSGTVFPDJGHOG-UHFFFAOYSA-N
Synonym1,3,4-Thiadiazole-2-carbonitrile, 5-chloro-;5-chloro-1,3,4-thiadiazole-2-carbonitrile
CAS No.195737-25-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZMUD460 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEYLW318 route compound structure diagram
    ACEYLW31864837-52-1In Stock
  2. Then
  3. ACZMUD460 route product structure diagram
    ACZMUD460195737-25-8
Inquiry

2. ACZMUD460 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACZMUD460 route product structure diagram
    ACZMUD460195737-25-8
Inquiry

3. ACZMUD460 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACZMUD460 route product structure diagram
    ACZMUD460195737-25-8
Inquiry

Comments (0)